FDA
approval
· 2020-02-25
FDA Approved: RANOLAZINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin Pharmaceuticals' supplemental application to market a generic Ranolazine product. This approval pertains to a generic version under ANDA 2010…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RANOLAZINE (RANOLAZINE)